Peptide Stacking Guide: How to Combine Peptides for Research
Peptide stacking is the practice of combining two or more peptides in a research protocol, based on the principle that compounds with complementary mechanisms can produce broader or more synergistic effects than any single peptide alone. Understanding which peptides can be combined — and the scientific rationale for doing so — requires understanding the mechanisms of each compound and how those mechanisms interact.
The core principle: mechanistic complementarity
The scientific rationale for any peptide stack should be mechanistic complementarity — the two compounds work through different pathways that together address a goal more completely than either alone. This is distinct from redundancy (two compounds doing the same thing) and from synergy (two compounds amplifying each other's effects through shared pathway interactions). The best-evidenced stacks are complementary: BPC-157 and TB-500 address vascularization and cell migration respectively; SS-31 and MOTS-c address membrane repair and biogenesis respectively; CJC-1295 and Ipamorelin address GHRH stimulation and GH release respectively.
Redundant stacking — combining two compounds that work through the same pathway — adds complexity and cost without clear mechanistic benefit. Stacking two GHRPs (growth hormone releasing peptides), for example, does not produce more GH release than using the stronger GHRP alone at an appropriate dose.
Healing and repair stacks
The Wolverine Stack (BPC-157 + TB-500) is the most evidenced healing combination in preclinical research. See the Wolverine Stack research guide for the full mechanistic breakdown. The combination is available as a pre-formulated Wolverine Blend in the database.
The Glow Stack (GHK-Cu + BPC-157 + TB-500) adds the copper tripeptide GHK-Cu to the Wolverine pair for skin and connective tissue applications. GHK-Cu activates approximately 31% of human tissue remodeling genes and upregulates collagen and elastin synthesis — adding a structural rebuilding mechanism to the vascularization and cell migration signals from BPC-157 and TB-500. Available as the Glow Blend in the database.
Growth hormone stacks
The foundational GH stack pairs a GHRH (growth hormone releasing hormone) analogue with a GHRP (growth hormone releasing peptide). These compounds work through distinct receptor systems that converge on pituitary GH release: GHRH analogues (CJC-1295, Sermorelin, Tesamorelin) stimulate the GHRH receptor to amplify GH pulse amplitude. GHRPs (Ipamorelin, GHRP-2, GHRP-6, Hexarelin) stimulate the ghrelin/GHSR receptor to trigger GH release pulses. Combining a GHRH and a GHRP produces synergistically greater GH release than either alone, because they act on different receptor systems that both converge on pituitary somatotrophs.
The most common researched combinations: CJC-1295 No DAC with Ipamorelin (lean muscle and fat-to-muscle composition), Tesamorelin with Ipamorelin (anti-aging and visceral fat reduction), and the Tesamorelin/Ipamorelin/MGF combination for athletic recovery. All are available as pre-formulated blends in the database.
Mitochondrial stacks
The Mito Stack (SS-31 + MOTS-c + NAD+) targets three distinct failure points in mitochondrial energy production. See the Mito Stack research guide for the complete protocol. The sequencing of this stack matters — SS-31 first to repair the membrane, then MOTS-c to build biogenesis on the repaired foundation, with NAD+ supporting both phases.
Longevity stacks
The Khavinsky longevity protocol (Epithalon + Thymalin + Pinealon) targets the pineal gland, thymus, and brain cortex simultaneously. See the Khavinsky Protocol research guide. Epithalon is also commonly combined with GHK-Cu for a comprehensive anti-aging approach — Epithalon addressing telomere length and melatonin restoration while GHK-Cu addresses skin, hair, and tissue remodeling gene expression.
Cognitive stacks
The Calm and Clarity blend (Pinealon + PE-22-28 + Selank) targets three distinct cognitive mechanisms: epigenetic memory gene regulation (Pinealon), neuroprotection and mood stabilization (PE-22-28), and GABAergic anxiety reduction with dopamine/serotonin modulation (Selank). No mechanism overlap — all three are additive. Available as a pre-formulated blend in the database.
Key considerations for any stack
Injection timing matters for some stacks and not others. Growth hormone peptides should be taken fasted — food intake blunts GH pulse. Healing peptides like BPC-157 and TB-500 show no significant food-timing effects. Mitochondrial peptides are typically administered in the morning. When multiple injections are used on the same day, allow at least 30–60 minutes between injections unless using a pre-formulated blend. Always start new protocols one compound at a time when possible, adding additional compounds after a baseline response is established. The Peptide Hub dosing guide and interactive calculators are designed to support multi-peptide protocol planning.